TrialPanorama/TrialPanorama-database huggingface dataset:
Study: NCT05533944

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Simulation training in Boškoski-Costamagna ERCP Trainer
Description: Coached simulation training in Boškoski-Costamagna ERCP Trainer, by participating in three intensive courses during the first three months of training, with a monthly basis
Study: NCT06365658

Intervention type: DIAGNOSTIC_TEST
Intervention: Psychological assessment
Description: Psychological assessment of memory, learning and language

Intervention type: DIAGNOSTIC_TEST
Intervention: Psychological assessment
Description: Psychological assessment of memory, learning and language

Intervention type: DIAGNOSTIC_TEST
Intervention: Psychological assessment
Description: Psychological assessment of memory, learning and language
Study: NCT04884880

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Luo-Fu-Shan Plaster
Description: Luo-Fu-Shan Plaster 10g，once daily，4 weeks

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: The placebo 10g
Description: Placebo 10g，once daily，4 weeks
Study: NCT05010070

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: diet and lifestyle program
Description: See description of main arm.
Study: NCT05895305

Intervention type: COMBINATION_PRODUCT
Group type: EXPERIMENTAL
Intervention: Paclitaxel-Coated Pulmonary Balloon Catheter
Description: Subjects with benign airway stenosis will be treated by Airiver pulmonary DCB at index procedure
Study: NCT06120686

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Biofeedback method
Description: Study group - implementing a conventional therapy program supplemented additionally with visual and auditory biofeedback training on a dynamic balance platform

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Conventional therapy program
Description: Control group - rehabilitation management aimed at improving cognitive and motor functions in children with mild intellectual disabilities.

Intervention type: OTHER
Group type: OTHER
Intervention: Conventional therapy program
Description: Control group - rehabilitation management aimed at improving cognitive and motor functions in children with mild intellectual disabilities.
Study: NCT05745103

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Cognitive behavioral therapy with AI
Description: Cognitive behavioral therapy is a psycho-social intervention that aims to reduce symptoms of various mental health conditions, primarily depression and anxiety disorders. The Eleos Health platform provides real-time data that optimizes this therapy and helps the provider tailor the intervention to the specific client.

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Cognitive behavioral therapy
Description: Cognitive behavioral therapy is a psycho-social intervention that aims to reduce symptoms of various mental health conditions, primarily depression and anxiety disorders.
Study: NCT04819529

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Early and Intensive Occupational Therapy
Description: Occupational therapists will implement the following activities:~* Polysensory stimulation: external stimulation for increasing the level of alertness. It will be implemented with SAS 1 one session each 48 h and SAS 2 one session each 24 h.~* Cognitive stimulation: bundle of exercises for activating mental functions, i.e: alertness, visual perception, memory, calculus, problem solving, praxis, language. Patients with SAS 3, 4 and 5. In SAS \<2, 6\> environmental orientation will be considered~* Basic activities of daily living (BADLs): promotion of independence that initially practice hygiene, personal grooming. Patients with SAS 3, 4 and 5~* Motor function Stimulation: exercises to keep the patient's upper extremities active and functional. Patients with SAS with 3,4 and 5. Patients with SAS 1 and 2 will use adaptations to prevent edema and bedsores on vulnerable body areas~* Education: daily visits by trained family members and health staff about the intervention process
Study: NCT06043180

Intervention type: PROCEDURE
Intervention: Transcatheter aortic valve implantation
Description: Intervention on aortic valve for severe aortic stenosis
Study: NCT05980065

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: C1K
Description: Subcutaneously administrate C1K 150mg at 0 Day 1, Day 8, Day 15

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: C1K
Description: Subcutaneously administrate C1K 300mg at 0 Day 1, Day 8, Day 15

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Placebo
Description: Subcutaneously administrate placebo at 0 Day 1, Day 8, Day 15

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Placebo
Description: Subcutaneously administrate placebo at 0 Day 1, Day 8, Day 15

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Placebo
Description: Subcutaneously administrate placebo at 0 Day 1, Day 8, Day 15

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Placebo
Description: Subcutaneously administrate placebo at 0 Day 1, Day 8, Day 15

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: C1K
Description: Subcutaneously administrate C1K 600mg at 0 Day 1, Day 8, Day 15

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: C1K
Description: Subcutaneously administrate C1K 900mg at 0 Day 1, Day 8, Day 15

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: C1K
Description: Subcutaneously administrate C1K 1200mg at 0 Day 1, Day 8, Day 15
Study: NCT06547762

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Hybrid approach (in-person and remote) to pediatric rehabilitation: A look beyond the COVID-19 crisis
Description: Hybrid rehabilitation. Out patients will receive one day a week of remote therapy and the remaining (1-4 days) in person at rehabilitation hospital
Study: NCT04858607

Intervention type: DIAGNOSTIC_TEST
Intervention: Blood sample
Description: Serology, immune status, T cell immunity, and T cell aging.

Intervention type: DIAGNOSTIC_TEST
Intervention: Blood sample
Description: Serology, immune status, T cell immunity, and T cell aging.

Intervention type: DIAGNOSTIC_TEST
Intervention: Saliva sample
Description: Antibody tests

Intervention type: DIAGNOSTIC_TEST
Intervention: Saliva sample
Description: Antibody tests
Study: NCT05417672

Intervention type: DIAGNOSTIC_TEST
Intervention: Nutritional Risk Screening-2002
Description: Nutritional Risk Screening-2002

Intervention type: DIAGNOSTIC_TEST
Intervention: Nutritional Risk Index
Description: Nutritional Risk Index

Intervention type: DIAGNOSTIC_TEST
Intervention: Mini Nutritional Assessment
Description: Mini Nutritional Assessment

Intervention type: DIAGNOSTIC_TEST
Intervention: Glasgow Prognostic Score
Description: Glasgow Prognostic Score

Intervention type: DIAGNOSTIC_TEST
Intervention: Prognostic Nutritional Index
Description: Prognostic Nutritional Index
Study: NCT05830968

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Morpheus8 Applicator Radiofrequency device
Description: Eligible subjects will receive 2 treatments with the Morpheus8 according to the study protocol. All participants will return for 2 follow up visits: 4 weeks (1M FU) and 12 weeks (3M FU) after the 2nd treatment. Total expected study duration is \~6 months, depending on subject recruitment rate.
Study: NCT05722782

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Piroxicam
Description: Patients allocated to this arm received , as a second line treatment of renal colics , a five days treatment with 20 mg piroxicam per day and were contacted at the seventh day by telephone call to investigate the efficacy and the side effects of the treatment

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Acetaminophen
Description: Patients allocated to this arm received , as a second line treatment of renal colics , a five days treatment with 1000 mg Acetaminophen per day and were contacted at the seventh day by telephone call to investigate the efficacy and the side effects of the treatment

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Patients allocated to this arm received , as a second line treatment of renal colics , a five days treatment with placebo per day and were contacted at the seventh day by telephone call to investigate the efficacy and the side effects of the treatment
Study: NCT06065397

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Goal setting improvement program
Description: A improvement program how to optimalize patient-centered goal setting in rehab care is being implemented.
Study: NCT06347783

Intervention type: DEVICE
Intervention: Insulin pump
Description: Continuous subcutaneous insulin therapy.
Study: NCT05285267

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Behavioral Parent Support
Description: Parent training on effective child management strategies

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Behavioral Parent Support
Description: Parent training on effective child management strategies

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Shared Parent-Child Activities
Description: Structured parent-child activities

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: COACHES
Description: This intervention involves practice of parenting strategies with facilitator monitoring and support.
Study: NCT05133336

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Saroglitazar Magnesium 1 mg
Description: Subjects randomized to Saroglitazar Magnesium 1 mg arm will receive Saroglitazar Magnesium 1 mg treatment for the entire treatment period up to Week 52.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Saroglitazar Magnesium 1 mg
Description: Subjects randomized to Saroglitazar Magnesium 1 mg arm will receive Saroglitazar Magnesium 1 mg treatment for the entire treatment period up to Week 52.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Saroglitazar Magnesium 2 mg
Description: Subjects randomized to Saroglitazar Magnesium 2 mg arm are switched to Saroglitazar Magnesium 1 mg treatment up to Week 52

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Subjects randomized to placebo arm will receive placebo treatment for the entire treatment period up to Week 52.
Study: NCT05417672

Intervention type: DIAGNOSTIC_TEST
Intervention: Anthropometric measurements
Description: middle arm circumference

Intervention type: DEVICE
Intervention: Handgrip strength test
Description: Handgrip strength test
Study: NCT04230616

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: total knee arthroplasty
Description: total knee arthroplasty

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: total knee arthroplasty
Description: total knee arthroplasty

Intervention type: RADIATION
Group type: ACTIVE_COMPARATOR
Intervention: CT scan
Description: The first 52 participants will recieve a pre- and postoperative CT scan of the hip, knee and ankle.

Intervention type: RADIATION
Group type: ACTIVE_COMPARATOR
Intervention: CT scan
Description: The first 52 participants will recieve a pre- and postoperative CT scan of the hip, knee and ankle.
Study: NCT05940389

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Naso Alveolar Mold
Description: The NAM appliance is constructed according to the Grayson technique \[8\] with the nasal stent added from the start. The adhesive paste is used to hold the alveolar plate in place and labial taping is used. Patients are followed each 2 to 3 weeks for the appliance to be relined and selectively ground to modify the pressure as needed.

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Taping with nasal elevator:
Description: For the lip approximation, Airoplast tape is used which is water resistant transparent and coated with hypoallergic adhesive on one side. The nasal elevator is 3D printed from the design inspired by the Dynacleft nasal elevator. Patients will be followed each 2 to 3 weeks for any modifications or adjustments.
Study: NCT05563051

Intervention type: DEVICE
Group type: OTHER
Intervention: i-ED COIL
Description: The i-ED COIL System (i-ED COIL and detachment box) are intended for the endovascular embolization of intracranial aneurysms and other neurovascular abnormalities such as arteriovenous malformations and arteriovenous fistulae.
Study: NCT06059092

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Adapt Module
Description: In each intervention, participants will be trained selected psychological skills using cognitive-behavioral-inspired techniques related to coping strategies, locus of control, coping metacognition, positive psychology strategies. Activities will involve brainstorming and exercises based on fictional situations, allowing active participation and reflection as well as feedback from animators and peers. Activities and aids have been designed to meet adolescents' developmental level, concerns and capacities and to support effective learning. Participants will be asked to carry out home tasks to practice learned skills. They will also be provided additional resources related to their module's thematic, accessible through a workbook and a website.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Engage Module
Description: In each intervention, participants will be trained selected psychological skills using cognitive-behavioral-inspired techniques related to goal setting, planning, strengths identification, motivation; goal pursuit metacognition. Activities will involve brainstorming and exercises based on fictional situations, allowing active participation and reflection as well as feedback from animators and peers. Activities and aids have been designed to meet adolescents' developmental level, concerns and capacities and to support effective learning. Participants will be asked to carry out home tasks to practice learned skills. They will also be provided additional resources related to their module's thematic, accessible through a workbook and a website.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Interact Module
Description: In each intervention, participants will be trained selected psychological skills using cognitive-behavioral-inspired techniques related to social cognition, assertive communication and conflict resolution, proactive prosocial behaviors, interactional metacognition. Activities will involve brainstorming and exercises based on fictional situations, allowing active participation and reflection as well as feedback from animators and peers. Activities and aids have been designed to meet adolescents' developmental level, concerns and capacities and to support effective learning. Participants will be asked to carry out home tasks to practice learned skills. They will also be provided additional resources related to their module's thematic, accessible through a workbook and a website.

Intervention type: BEHAVIORAL
Group type: PLACEBO_COMPARATOR
Intervention: Control Group
Description: Sessions will be devoted to serious game training cognitive and executive functions through individual and group activities based on board games.
Study: NCT04690517

Intervention type: PROCEDURE
Group type: OTHER
Intervention: tracheal ultrasound
Description: When checking tracheal ultrasound, several signs are used in judgements. Direct signs include reverberation artifact and double ring sign. Indirect sign means checking the bilateral lung sliding.
Study: NCT06449326

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Active Intermittent theta burst stimulation
Description: Intermittent theta burst stimulation (iTBS) is an efficient form of transcranial magnetic stimulation that allows up to 10x more pulses to be delivered in a given timeframe compared to conventional stimulation patterns.

Intervention type: DEVICE
Group type: SHAM_COMPARATOR
Intervention: Sham Intermittent theta burst stimulation
Description: Intermittent theta burst stimulation (iTBS) is an efficient form of transcranial magnetic stimulation that allows up to 10x more pulses to be delivered in a given timeframe compared to conventional stimulation patterns.
Study: NCT05873010

Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: Manual Compression and Stretching
Description: Manual Compression and Stretching for The Myofascial Trigger Points
Study: NCT05912907

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: potassium nitrate in polycarboxilate cement
Description: 5% potassium nitrate in polycarboxylate; pre-weighed 95 mg zinc oxide powder and 5mg of KNO3 will be placed on a glass slab followed by mixing by polyacrylic acid (liquid) in a 1:1 P/L ratio

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: potassium nitrate in polycarboxilate cement
Description: 5% potassium nitrate in polycarboxylate; pre-weighed 95 mg zinc oxide powder and 5mg of KNO3 will be placed on a glass slab followed by mixing by polyacrylic acid (liquid) in a 1:1 P/L ratio
Study: NCT05941689

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: AI-assisted colonoscopy
Description: AI can not only detect suspicious lesions timely, and label them in the field of view of the colonoscopy, but also monitor withdrawal speed and calculate the clean withdrawal time automatically.
Study: NCT05581290

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: AI-Flex
Description: A flexible multi-modal bio-sensing device with integrated AI capability used to measure ECG (heart's electrical activity), body temperature, and PPG (blood volume in tissue); primarly mounted on the wrist and chest.
Study: NCT05498402

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: i-gel ® device
Description: Ventilations will be delivered through an i-gel ® device

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: bag-valve-mask ventilation
Description: Ventilations will be delivered using a bag-valve-mask
Study: NCT06473298

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Visual Light Tracking
Description: visual light tracking program consists of 10 tasks every task lasts for 6 minutes and may be repeated for the child especially in the first sessions to give him trials to him/her to understand the exercise.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Visual Light Tracking
Description: visual light tracking program consists of 10 tasks every task lasts for 6 minutes and may be repeated for the child especially in the first sessions to give him trials to him/her to understand the exercise.
Study: NCT06117917

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: S-ketamine and pregabalin
Description: * Drug: Pregabalin~* 150mg (2hrs) pre operatively and 75mg twice daily post operatively for 7 days(POD1-7), followed by dose reduction to 75mg once daily for 7 days(POD8-14)~* Drug: S-ketamine infusion~* 0.5 mg/kg bolus after induction of anesthesia +0.12 mg/kg/h continuous intravenous infusion for 48 h

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Normal saline and placebo capsule
Description: * Drug: Placebo capsules~* Two placebo capsules (2hrs) preoperatively and twice daily post operatively for 7days, followed by dose reduction to single capsule once daily for 7days~* Drug: Normal saline~* 0.9% saline bolus after induction of anesthesia + intravenous infusion for 48 hours
Study: NCT05322915

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: line dancing
Description: The intervention included 60-minute sessions, two days a week for four weeks for a total of eight sessions. All sessions were administered by the physiotherapist who has 26 years of experience in dance therapy. The dance was performed on a one to one basis with minimal support from the therapist. The line dancing sequence, which was specially created for this training program, was designed as a structured goal-oriented dance. Line dancing movements/steps are comprised of moving forward and backward, or sideways and turns and scuff. In addition, the fact that one foot is always in contact with the ground makes it ideal for patients with multiple sclerosis, who may have balance problems.
Study: NCT05226351

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Dronabinol 2.5 mg
Description: single administration of 2.5mg Dronabinol oral (oily solution)

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Dronabinol 2.5 mg
Description: single administration of 2.5mg Dronabinol oral (oily solution)

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: single administration of placebo oral (oily solution)

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: single administration of placebo oral (oily solution)
Study: NCT06290492

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: transcranial direct current stimulation
Description: tDCS is described as a non-invasive form of brain stimulation that uses a low-intensity, direct current applied directly to the head through scalp electrodes

Intervention type: DEVICE
Group type: SHAM_COMPARATOR
Intervention: sham transcranial direct current stimulation
Description: Sham tDCS was delivered using the same protocol and current intensity, but the period of active stimulation was only during the ramp-up and ramp-down periods of 30 and 30 seconds.
Study: NCT04774380

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Durvalumab
Description: Participants will receive durvalumab via IV infusion on Day 1 of each cycle.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Cisplatin
Description: Participants will receive cisplatin via IV administration on Day 1 of each cycle.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Carboplatin
Description: Participants will receive carboplatin via IV administration Day 1 of each cycle.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Etoposide
Description: Participants will receive etoposide via IV administration on days 1 to 3 of each cycle.